The Federal Trade Commission has issued a Second Request for information regarding MiMedx Group's proposed merger with Sanara MedTech.
SEC EDGAR, 2026-10-16: 8-K (Item 8.01) — "second request"
The Federal Trade Commission has issued a Second Request for information regarding MiMedx Group's proposed merger with Sanara MedTech.
Company: MIMEDX GROUP, INC. (MDXG) Filed: October 16, 2026, 8-K (Item 8.01) Phrase: "second request" — "On October 15, 2026, the Company and Sanara each received a request for additional information and documentary materials (a “Second Request”) from the Federal Trade Commission (the “FTC”) in connection with the FTC’s review of the Merger." What the filing says: MiMedx Group, Inc. and Sanara MedTech Inc. each received a Second Request from the Federal Trade Commission on October 15, 2026, in connection with the FTC's review of their proposed merger. The Second Request extends the Hart-Scott-Rodino Antitrust Improvements Act waiting period until 30 days after both parties substantially comply, unless the period is voluntarily extended by the parties or terminated earlier by the FTC. Completion of the merger remains subject to the expiration or termination of this waiting period. Two ways it goes: A. The FTC clears the merger after the parties comply with the Second Request. B. The FTC sues to block the merger on antitrust grounds. Next date: none named Watch: A public regulatory update or filing confirming substantial compliance with the Second Request or an FTC decision to either clear or challenge the transaction.